Faderl S - Search Results

1

High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.

Beran M, Shen Y, Kantarjian H, O'Brien S, Koller CA, Giles FJ, Cortes J, Thomas DA, Faderl S, Despa S, Estey EH. Beran M, et al. Among authors: faderl s. Cancer. 2001 Oct 15;92(8):1999-2015. doi: 10.1002/1097-0142(20011015)92:8<1999::aid-cncr1538>3.0.co;2-b. Cancer. 2001. PMID: 11596013

2

Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia.

Giles FJ, Cortes JE, Thomas DA, Garcia-Manero G, Faderl S, Jeha S, De Jager RL, Kantarjian HM. Giles FJ, et al. Among authors: faderl s. Clin Cancer Res. 2002 Jul;8(7):2134-41. Clin Cancer Res. 2002. PMID: 12114413 Clinical Trial.

3

Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.

Giles FJ, Kantarjian HM, Cortes JE, Faderl S, Verstovsek S, Thomas D, Garcia-Manero G, Wierda W, Ferrajoli A, Kornblau S, Mattiuzzi GN, Tsimberidou AM, Albitar M, O'Brien SM, Estey E. Giles FJ, et al. Among authors: faderl s. Leuk Res. 2005 Jun;29(6):649-52. doi: 10.1016/j.leukres.2004.11.013. Epub 2005 Apr 1. Leuk Res. 2005. PMID: 15863204 Clinical Trial.

4

Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.

Faderl S, Thall PF, Kantarjian HM, Talpaz M, Harris D, Van Q, Beran M, Kornblau SM, Pierce S, Estrov Z. Faderl S, et al. Clin Cancer Res. 1999 Dec;5(12):4041-7. Clin Cancer Res. 1999. PMID: 10632337

5

The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.

Faderl S, Kantarjian HM, Estey E, Manshouri T, Chan CY, Rahman Elsaied A, Kornblau SM, Cortes J, Thomas DA, Pierce S, Keating MJ, Estrov Z, Albitar M. Faderl S, et al. Cancer. 2000 Nov 1;89(9):1976-82. doi: 10.1002/1097-0142(20001101)89:9<1976::aid-cncr14>3.3.co;2-e. Cancer. 2000. PMID: 11064355

6

Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.

Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ, Thomas D, Cortes J, Andreeff M, Estrov Z, Rios MB, Albitar M. Ravandi F, et al. Among authors: faderl s. Cancer. 2001 Jun 1;91(11):1964-72. doi: 10.1002/1097-0142(20010601)91:11<1964::aid-cncr1221>3.0.co;2-b. Cancer. 2001. PMID: 11391574

7

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, Thomas DA, Garcia-Manero G, Ferrajoli A, Manning JT, Keating MJ, Albitar M, O'Brien S, Giles FJ. Tsimberidou AM, et al. Among authors: faderl s. Leukemia. 2003 Jun;17(6):1100-3. doi: 10.1038/sj.leu.2402958. Leukemia. 2003. PMID: 12764375

8

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome.

Garg R, Faderl S, Garcia-Manero G, Cortes J, Koller C, Huang X, York S, Pierce S, Brandt M, Beran M, Borthakur G, Kantarjian H, Ravandi F. Garg R, et al. Among authors: faderl s. Leukemia. 2009 Jul;23(7):1297-302. doi: 10.1038/leu.2009.28. Epub 2009 Feb 26. Leukemia. 2009. PMID: 19242494 Free PMC article. Clinical Trial.

9

Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome.

Tambaro FP, Garcia-Manero G, O'Brien SM, Faderl SH, Ferrajoli A, Burger JA, Pierce S, Wang X, Do KA, Kantarjian HM, Keating MJ, Wierda WG. Tambaro FP, et al. Among authors: faderl sh. Leukemia. 2016 Feb;30(2):325-30. doi: 10.1038/leu.2015.227. Epub 2015 Aug 20. Leukemia. 2016. PMID: 26290497 Free PMC article.

10

Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.

Alvarado Y, Cortes J, Verstovsek S, Thomas D, Faderl S, Estrov Z, Kantarjian H, Giles FJ. Alvarado Y, et al. Among authors: faderl s. Cancer Chemother Pharmacol. 2003 Jan;51(1):81-6. doi: 10.1007/s00280-002-0533-4. Epub 2002 Nov 21. Cancer Chemother Pharmacol. 2003. PMID: 12497210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

386 results

Search Page